Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$223M |
| 2 |
TJX Companies
TJX
|
+$191M |
| 3 |
TransDigm Group
TDG
|
+$157M |
| 4 |
Ingersoll Rand
IR
|
+$155M |
| 5 |
BP
BP
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 2 |
Eaton
ETN
|
+$261M |
| 3 |
Union Pacific
UNP
|
+$252M |
| 4 |
Analog Devices
ADI
|
+$240M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.39% |
| 2 | Financials | 11.28% |
| 3 | Technology | 9.98% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Fortune Brands Innovations
FBIN
$5.32B
| $17.1M | 0.05% |
298,601
+268,285
| +885% | +$14.1M |
|
527
Arcturus Therapeutics
ARCT
$382M
| $17M | 0.05% |
1,004,235
+664,852
| +196% | +$11.6M |
|
|
MASI
528
DELISTED
Masimo
MASI
| $16.9M | 0.05% |
114,336
+97,831
| +593% | +$13.5M |
|
529
Carter's
CRI
$1.31B
| $16.8M | 0.05% |
+225,671
| New | +$16.2M |
|
530
CALL
Deere & Co
DE
$175B
| $16.8M | 0.05% |
39,200
+14,200
| +57% | +$5.77M |
|
531
Vontier
VNT
$4.46B
| $16.8M | 0.05% |
868,815
-948,136
| -52% | -$17.8M |
|
532
Avery Dennison
AVY
$13.9B
| $16.8M | 0.05% |
92,672
-65,646
| -41% | -$11.7M |
|
533
Under Armour
UAA
$2.32B
| $16.8M | 0.05% |
1,650,126
-2,508,492
| -60% | -$21.7M |
|
534
Jack in the Box
JACK
$331M
| $16.6M | 0.05% |
243,229
+97,247
| +67% | +$7.47M |
|
535
Mercado Libre
MELI
$97.5B
| $16.6M | 0.05% |
19,583
-39,737
| -67% | -$35.4M |
|
536
First Interstate BancSystem
FIBK
$3.57B
| $16.5M | 0.05% |
427,239
-64,255
| -13% | -$2.72M |
|
537
Teva Pharmaceuticals
TEVA
$43.5B
| $16.4M | 0.05% |
+1,803,540
| New | +$15.7M |
|
|
ENLC
538
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $16.4M | 0.04% |
+1,332,620
| New | +$15.4M |
|
539
Leslie's
LESL
$5.63M
| $16.3M | 0.04% |
+66,848
| New | +$18.6M |
|
540
Synchrony
SYF
$25.9B
| $16.3M | 0.04% |
496,427
+461,427
| +1,318% | +$15.8M |
|
541
Martin Marietta Materials
MLM
$32.1B
| $16.2M | 0.04% |
48,016
-158,719
| -77% | -$54.1M |
|
542
Coupang
CPNG
$29.6B
| $16.1M | 0.04% |
+1,093,153
| New | +$19.3M |
|
|
NVRO
543
DELISTED
NEVRO CORP.
NVRO
| $16M | 0.04% |
405,044
-135,999
| -25% | -$5.66M |
|
544
CALL
Bank of America
BAC
$431B
| $16M | 0.04% |
482,600
+332,600
| +222% | +$11.5M |
|
545
AES
AES
$10.5B
| $15.9M | 0.04% |
+553,110
| New | +$14.9M |
|
|
ARTE
546
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
| $15.9M | 0.04% |
1,550,000
| – | – |
|
547
Booking.com
BKNG
$158B
| $15.8M | 0.04% |
195,925
+29,350
| +18% | +$2.23M |
|
548
Allstate
ALL
$64.2B
| $15.8M | 0.04% |
116,472
-323,855
| -74% | -$42.4M |
|
|
IMGO
549
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $15.7M | 0.04% |
+438,089
| New | +$11M |
|
550
Quanta Services
PWR
$96.1B
| $15.7M | 0.04% |
110,482
-396,911
| -78% | -$56.4M |
|
Similar funds
Dmitry Balyasny's Q4 2022 Portfolio in Review
As of Q4 2022, Dmitry Balyasny held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Dmitry Balyasny's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
- Dmitry Balyasny's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
- Dmitry Balyasny added most to Visa in Q4 2022, an estimated $223M increase.
- Dmitry Balyasny's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
- Dmitry Balyasny fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
- Dmitry Balyasny's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
- Dmitry Balyasny opened 780 new positions and closed 866 in Q4 2022.
- Dmitry Balyasny's portfolio value rose 12% quarter-over-quarter to $36.5B.
Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.